2016 American Transplant Congress

Sunday, June 12, 2016

6:00pm-7:00pm

A 15-Year Retrospective Analysis of Acute Kidney Injury in Non Renal Solid Organ Transplant Recipients: Incidence, Outcome and Progression Toward End Stage Chronic Kidney Disease.

V. Cantaluppi,¹ A. Quercia,² S. Dellepiane,² D. Medica,² L. Biancone.²

Poster Session B: Disparities in Access and Outcomes  •  Halls C&D

6:00pm-7:00pm

A Call for a New Paradigm of Organ Allocation within the Confines of MELD for Those Who Are Not “the Sickest”.

T. Baker, A. Siarris, P. Accoh, D. Ladner.

Poster Session B: Liver: MELD, Allocation and Donor Issues (DCD/ECD)  •  Halls C&D

6:00pm-7:00pm

A Comprehensive Biomarker Study to Compare Tacrolimus and Mycophenolic Acid versus Half-Dose Tacrolimus and Everolimus in De Novo Kidney Transplant Patients in the Novartis US92 Study.

J. Klepacki,¹ J. Klawitter,¹ J. Klawitter,¹ A. Karimpour-fard,² E. Anderson,¹ G. Ingle,³ D. Patel,³ K. Johnson,⁴ D. Cibrik,⁴ U. Christians.¹

Poster Session B: Drug Minimization  •  Halls C&D

6:00pm-7:00pm

A Genome Wide Association Study of New Onset Diabetes After Transplant in Kidney Transplantation.

A. Giri,¹ M. Sanders,² D. Velez Edwards,¹ T. Ikizler,³ D. Roden,³ K. Birdwell.³

Poster Session B: Kidney: Cardiovascular and Metabolic  •  Halls C&D

6:00pm-7:00pm

A Multi-Modular Approach for Training in Liver Procurement Accelerates Proficiency Gain.

I. Al Hasan,^1,2 H. Sharma,^1,2 M. Tun-Abraham,¹ D. Quan.^1,2

Poster Session B: Donor Management: All Organs  •  Halls C&D

6:00pm-7:00pm

A Novel Humanized Mouse Model Incorporating Non-Fetal Tissue.

M. Brown, I. Norman, Y. Zhou, W. Lou, J. Sullivan, W. Burlingham.

Poster Session B: Allograft Rejection, Tolerance, and Xenotransplantation  •  Halls C&D

6:00pm-7:00pm

A Novel Inflammation-Targeting Tacrolimus Hydrogel for Liver Transplantation.

J. Jia,¹ J. Li,¹² Y. Zhou,¹ L. Jiang,¹ J. Zhang,¹ H. Lu,¹ H. Xie,¹ L. Zhou,¹ P. Kumur,³ S. Zheng.¹²

Poster Session B: Allograft Rejection, Tolerance, and Xenotransplantation  •  Halls C&D

6:00pm-7:00pm

A Randomized-Controlled Trial Comparing the Efficacy of CYP3A5 Genotype-Based with Bodyweight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation.

N. Shuker,^1,2 R. Bouamar,² R. van Schaik,³ M. Clahsen -van Groningen,⁴ J. Damman,⁵ C. Baan,¹ J. van de Wetering,¹ A. Rowshani,¹ W. Weimar,¹ T. van Gelder,^1,2 D. Hesselink.¹

Poster Session B: Drug Minimization  •  Halls C&D

6:00pm-7:00pm

A Successful Approach to Kidney Transplantation in Patients with Secondary Hyperoxaluria.

J. Roodnat,¹ A. Mik-van Egmond,² W. Visser,² S. Berger,³ W. van der Meijden,⁴ F. Knauf,⁵ M. Agteren van,¹ M. Betjes,¹ E. Hoorn.¹

Poster Session B: Kidney: Cardiovascular and Metabolic  •  Halls C&D

6:00pm-7:00pm

A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.

B. Kaplan, K. MaCague, D. Patel, F. Vincenti.

Poster Session B: Drug Minimization  •  Halls C&D